Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Norcross, GA
SEC filing record 1 source field available
Fiscal year end
31 December
GALECTIN THERAPEUTICS INC has filed 1,569 SEC EDGAR filings since 13 Jun 2001

SEC filing history

Showing 776-800 of 1,000 matching filings.

Per page
25
Current page
32
NT 10-K File 001-31791

NT-10K

Filing date
16 Mar 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
12 Mar 2015
Reporting date
06 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

FORM 8-K

Filing date
24 Feb 2015
Reporting date
24 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
24 Feb 2015
Reporting date
24 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Feb 2015
Reporting date
31 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
07 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
07 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2014
Reporting date
15 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

FORM 8-K

Filing date
12 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2014
Reporting date
18 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
10 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
10 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Sep 2014
Reporting date
23 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
24 Sep 2014
Reporting date
23 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
24 Sep 2014
Reporting date
23 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
15 Sep 2014
Reporting date
15 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
12 Sep 2014
Reporting date
12 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Aug 2014
Reporting date
19 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2014
Reporting date
15 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .